Tоpіc: phаrmаcy bеnеfіt mаnаgеmеnt
The Trump administration has outlined a number of policy changes it says will lower drug prices, but experts are skeptical.
After a one-day slump, Anthem's share spiraled upward after the insurer issued a strong quarterly earnings report.
Insurer stocks tanked after three big companies said they plan to start a new healthcare venture. But the jury's out on how much disruption is in store.
Health insurers say CMS “misses the mark” with a proposal aimed at tackling high drug prices in Medicare Part D.
Alex Azar reaffirmed his commitment to take on skyrocketing drug prices at his confirmation hearing on Tuesday.
The pharmaceutical industry has deflected blame for high drug prices onto pharmacy benefit managers and health insurers.
Few could argue that 2017 wasn't an eventful year for the health insurance industry. But 2018 is shaping up to be just as interesting,
CVS has reached an agreement with Aetna to purchase the health insurer for $69 billion.
With a deal between Aetna and CVS reportedly imminent, more questions are emerging about whether it will survive regulatory scrutiny.
CVS Health announced it will begin integrating individualized drug costs into e-prescription platforms to improve medication adherence.